ABSTRACT
BACKGROUND: The influence of Helicobacter-pylori (H. pylori) infection and the characteristics of gastric cancer (GC) on tumor-infiltrating lymphocyte (TIL) levels has not been extensively studied. Analysis of infiltrating-immune-cell subtypes as well as survival is necessary to obtain comprehensive information. AIM: To determine the rates of deficient mismatch-repair (dMMR), HER2-status and H. pylori infection and their association with TIL levels in GC. METHODS: Samples from 503 resected GC tumors were included and TIL levels were evaluated following the international-TILs-working-group recommendations with assessment of the intratumoral (IT), stromal (ST) and invasive-border (IB) compartments. The density of CD3, CD8 and CD163 immune cells, and dMMR and HER2-status were determined by immunohistochemistry (IHC). H. pylori infection was evaluated by routine histology and quantitative PCR (qPCR) in a subset of samples. RESULTS: dMMR was found in 34.4%, HER2+ in 5% and H. pylori-positive in 55.7% of samples. High IT-TIL was associated with grade-3 (P = 0.038), while ST-TIL with grade-1 (P < 0.001), intestinal-histology (P < 0.001) and no-recurrence (P = 0.003). dMMR was associated with high TIL levels in the ST (P = 0.019) and IB (P = 0.01) compartments, and ST-CD3 (P = 0.049) and ST-CD8 (P = 0.05) densities. HER2- was associated with high IT-CD8 (P = 0.009). H. pylori-negative was associated with high IT-TIL levels (P = 0.009) when assessed by routine-histology, and with high TIL levels in the 3 compartments (P = 0.002-0.047) and CD8 density in the IT and ST compartments (P = 0.001) when assessed by qPCR. A longer overall survival was associated with low IT-CD163 (P = 0.003) and CD8/CD3 (P = 0.001 in IT and P = 0.002 in ST) and high IT-CD3 (P = 0.021), ST-CD3 (P = 0.003) and CD3/CD163 (P = 0.002). CONCLUSION: TIL levels were related to dMMR and H. pylori-negativity. Low CD8/CD3 and high CD163/CD3 were associated with lower recurrence and longer survival.
ABSTRACT
OBJECTIVE: To evaluate the relationship between circulating tumor DNA (ctDNA) presence and tumor features including tumor-infiltrating lymphocyte (TIL) levels in Peruvian breast cancer patients. MATERIALS AND METHODS: This was a prospective study conducted at the Instituto Nacional de Enfemedades Neoplasicas, Peru. We evaluated level of TIL and PIK3CA mutations in ctDNA. Clinical characteristics, including outcome data, were collected from the patient file. Survival was calculated from the date of blood sample drawn to the event time. Data collected were analyzed using SPSS software version 25. RESULTS: We analyzed plasma samples from 183 breast cancer patients. most cases were of Luminal-B (44.8%) phenotype and stage II (41.5%), and median stromal TIL was 30%. PIK3CA mutation in ctDNA was detected in 35% cases (most with E545K) and was associated with lower TIL level (p=0.04). PIK3CA in ctDNA tended to be associated with advanced stages (p=0.09) in the whole series and with higher recurrence rates (p=0.053) in the non-metastatic setting. Patients with presence of PIK3CA in ctDNA tended to have shorter survival (p=0.083). CONCLUSION: Presence of PIK3CA mutation in ctDNA was frequently found in our Peruvian breast cancer series, was associated with lower TIL levels and tended to predict poor outcomes.
Subject(s)
Circulating Tumor DNA , Neoplasms , Lymphocytes, Tumor-Infiltrating/pathology , Peru , Prospective Studies , Class I Phosphatidylinositol 3-Kinases/genetics , Circulating Tumor DNA/genetics , Mutation , Biomarkers, Tumor/genetics , Neoplasms/pathologyABSTRACT
Background: Recent studies have shown that genetic alterations are associated with the effect of patient geographic location on gallbladder cancer development. Peru has a high incidence of gallbladder cancer, but causative factors have not yet been identified. We examined the frequency of mutations in TP53 and K-ras genes in Peruvian patients with gallbladder cancer, and compared this with data from Bolivia, Hungary, Chile, and Japan, which have a high gallbladder cancer incidence. Methods: DNA was extracted from formalin-fixed paraffin-embedded gallbladder tissue sections of 30 gallbladder cancer patients (9 men and 21 women) obtained using microdissection. Mutations in exons 5 to 8 of TP53 and codons 12, 13, and 61 of K-ras were examined using direct sequencing. Results: TP53 mutations were observed in 10 (33.3%) of patients, but K-ras mutations were absent. Nine (90%) TP53 mutations were point mutations (7 missense and 2 silent mutations), and the most frequent substitution was a G:C to A:T transition. G:C to A:T transitions at the CpG site or G:C to T:A transversions were found in one patient each. No significant differences were found in the frequency of TP53 and K-ras mutations among patients in the 5 countries. Conclusions: Our findings suggest that endogenous mechanisms and exogenous carcinogens may affect the carcinogenic process in Peruvian gallbladder cancer patients, similar to that in Bolivian patients. Further studies with a larger sample size are needed to clarify these findings.
Subject(s)
Gallbladder Neoplasms/genetics , Mutation/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Tumor Suppressor Protein p53/genetics , Adult , Aged , Aged, 80 and over , Bolivia , Exons/genetics , Female , Humans , Male , Middle Aged , Peru , Proto-Oncogene MasABSTRACT
INTRODUCTION: The Mortality-Incidence Ratio complement [1 - MIR] is an indicator validated in various populations to estimate five-year cancer survival, but its validity remains unreported in Peru. This study aims to determine if the MIR correlates directly with five-year survival in patients diagnosed with the ten most common types of cancer in metropolitan Lima. MATERIALS AND METHODS: The Metropolitan Lima Cancer Registry (RCLM in Spanish) for 2004-2005 was used to determine the number of new cases and the number of deaths of the following cancers: breast, stomach, prostate, thyroid, lung, colon, cervical, and liver cancers, as well as non-Hodgkin's lymphoma and leukaemia. To determine the five-year survival, the five-year vital status of cases recorded was verified in the National Registry of Identification and Civil Status (RENIEC in Spanish). A linear regression model was used to assess the correlation between [1 - MIR] and total observed five-year survival for the selected cancers. RESULTS: Observed and estimated five-year survival determined by [1 - MIR] for each neoplasia were thyroid (66.7%, 86.7%), breast (69.6%; 68%), prostate (64.3%, 63.8%) and cervical (50.1%, 58.5%), respectively. Pearson's r coefficient for the correlation between [MIR - 1] and observed survival was = 0.9839. Using the coefficient of determination, it was found that [1 - MIR] (X) captures the 96.82% of observed survival (Y). CONCLUSION: The Mortality-Incidence Ratio complement [1 - MIR] is an appropriate tool for approximating observed five-year survival for the ten types of cancers studied. This study demonstrates the validity of this model for predicting five-year survival in cancer patients in metropolitan Lima.
ABSTRACT
In order to determine the sociodemographic characteristics of human papillomavirus (HPV) in patients referred to the National Institute of Neoplastic Diseases (INEN) between 2012-2014, the detection of HPV in cervical cells was performed by polymerase chain reaction (PCR). In 465 cervical samples, 151 (32.5%) cases were HPV positive. The most common genotypes were HPV-16 (23.8%) and HPV-6 (11.9%). The presence of HPV was higher in women aged 17-29 years (OR = 2.64, 95% CI 1.14 to 6.13) and single women (OR = 2.31, 95% CI 1.37 to 3.91). The presence of genotypes of high-risk HPV was higher in single women (OR = 2.19, 95% CI 1.04 to 4.62). In conclusion, young and single women had a higher frequency of HPV-positive cases. Therefore participation by these groups should be emphasized in screening programs with combined molecular and cytological methods in order to detect the risk of developing cervical cancer in a timely manner.
Subject(s)
Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , Uterine Cervical Neoplasms/virology , Adolescent , Adult , Demography , Female , Genotype , Humans , Papillomavirus Infections/epidemiology , Peru/epidemiology , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears , Young AdultABSTRACT
Con el objetivo de determinar las características sociodemográficas del virus de pacientes con papiloma humano (VPH) referidas al Instituto Nacional de Enfermedades Neoplásicas (INEN) durante los años 2012-2014, se realizó la detección del VPH en células cervicales por reacción en cadena de la polimerasa (PCR). En 465 muestras cervicales se detectaron 151 (32,5%) casos de VPH positivas. Los genotipos más frecuentes fueron VPH-16 (23,8%) y VPH-6 (11,9%). La presencia de VPH fue mayor en mujeres de 17 a 29 años (OR 2,64, IC 95%:1,14-6,13) y solteras (OR 2,31, IC 95%: 1,37-3,91), la presencia de genotipos de VPH de alto riesgo fue mayor en solteras (OR 2,19, IC 95%: 1,04-4,62). En conclusión, mujeres jóvenes y solteras presentaron mayor frecuencia de casos VPH-positivos a quienes se debe enfatizar la participación en programas de tamizaje con métodos moleculares y citológicos combinados, a fin de detectar oportunamente el riesgo de desarrollar cáncer de cuello uterino...
In order to determine the sociodemographic characteristics of human papillomavirus (HPV) in patients referred to the National Institute of Neoplastic Diseases (INEN) between 2012-2014, the detection of HPV in cervical cells was performed by polymerase chain reaction (PCR). In 465 cervical samples, 151 (32.5%) cases were HPV positive. The most common genotypes were HPV-16 (23.8%) and HPV-6 (11.9%). The presence of HPV was higher in women aged 17-29 years (OR = 2.64, 95% CI 1.14 to 6.13) and single women (OR = 2.31, 95% CI 1.37 to 3.91). The presence of genotypes of high-risk HPV was higher in single women (OR = 2.19, 95% CI 1.04 to 4.62). In conclusion, young and single women had a higher frequency of HPV-positive cases. Therefore participation by these groups should be emphasized in screening programs with combined molecular and cytological methods in order to detect the risk of developing cervical cancer in a timely manner...
Subject(s)
Humans , Adolescent , Adult , Female , Child , Young Adult , Genotype , Polymerase Chain Reaction , Epidemiologic StudiesABSTRACT
BACKGROUND: Few studies have evaluated the trends in head and neck cancer in developing countries. The purpose of this study was to estimate trends in incidence of human papillomavirus-related (HPV-R) and HPV-unrelated (HPV-U) head and neck cancer in Lima, Peru, from 1987 to 2008. METHODS: Registry data from a single public cancer hospital were used to estimate age and sex-specific incidence rates. Annualized percent change was estimated using Poisson regression. RESULTS: The rate of total head and neck cancers, HPV-U, and HPV-R was 11.9, 10.9, and 0.8, respectively, per 100,000 person-years. Significant increases in HPV-U head and neck cancer were observed in men aged 30 to 44 (2.5%/year) and women 15 to 29 (4.2%/year), 30 to 44 (3.4%/year), and 60 to 74 (2.0%/year). Significant increases in HPV-R head and neck cancer were observed only among men aged 45 to 59 (9.6%/year). CONCLUSION: Although increased exposure to tobacco, occupational carcinogens, and changing sexual behaviors could be influencing these trends, additional analyses to assess generalizability of these findings to other regions of Peru are needed.
Subject(s)
Cancer Care Facilities , Head and Neck Neoplasms/epidemiology , Head and Neck Neoplasms/virology , Papillomaviridae/isolation & purification , Adolescent , Adult , Age Distribution , Aged , Confidence Intervals , Developing Countries , Female , Head and Neck Neoplasms/pathology , Humans , Incidence , Male , Middle Aged , Peru/epidemiology , Registries , Retrospective Studies , Sex Distribution , Survival Analysis , Urban Population , Young AdultABSTRACT
El presente estudio, aporta información oportuna en momentos enque el país cursa por conspícuos cambios demográficos y epidemiológicos, y cuando se inicia la modernización del sistema de salud. Asimismo se determinan las causas de enfermedad y lesiones que producen más años perdidos por muerte prematura y más años perdidos por discapacidad, lo que permite establecer un órden de las enfermedades y lesiones que tienen mayores consecuencias en la vida productiva del país, en el costo de atención y en la calidad de vida de la población peruana
Subject(s)
Disease/etiology , Epidemiology/organization & administration , Wounds and Injuries/epidemiology , PeruABSTRACT
El presente estudio contiene los estimados de los Años de Vida Saludables Perdidos (AVISA) de 135 subcategorías de causas de enfermedad y lesiones que agrupan a toda la patología que se produce en el país. A diferencia del primer reporte de Carga de Enfermedad realizado por el MINSA, estos estimados fueron hechos a partir de datos nacionales de morbilidad y mortalidad del año 2004, contrastados con parámetros epidemiológicos internacionales y validados con expertos nacionales en talleres de trabajo(AU)
Subject(s)
Disease , Wounds and Injuries , Data Interpretation, Statistical , Morbidity , Mortality , PeruABSTRACT
El presente estudio contiene los estimados de los Años de Vida Saludables Perdidos (AVISA) de 135 subcategorías de causas de enfermedad y lesiones que agrupan a toda la patología que se produce en el país. A diferencia del primer reporte de Carga de Enfermedad realizado por el MINSA, estos estimados fueron hechos a partir de datos nacionales de morbilidad y mortalidad del año 2004, contrastados con parámetros epidemiológicos internacionales y validados con expertos nacionales en talleres de trabajo
Subject(s)
Disease , Wounds and Injuries , Data Interpretation, Statistical , Morbidity , Mortality , PeruABSTRACT
La rafia es una zoonosis vírica endémica en el Perú. En el año 1996 ocurrieron dos casos en la población asegurada atendida por el Instituto Peruano de Seguridad Social (IPSS), para una tasa de incidencia de 0.03 por cien mil asegurados. Hasta el mes de octubre del año 19997, se han reportado la ocurrencia de tres casos (tasa de incidencia de 0.04 por cien mil asegurados), procedentes de las Gerencias Departamentales de Pucallpa y Junín. Todos los casos notificados en ambos años fallecieron, por lo que la tasa de letalidad fue de 100 por ciento. Este artículo tiene el propósito de contribuir a elevar el nivel de información sobre aspectos clínico-epidemiológicos, de comportamiento y manejo de la rabia humana en el Peró
